This excerpt taken from the ELN 6-K filed Apr 11, 2005.
Product Acquisitions and Alliances
At 31 December 2004, we included in creditors $Nil (2003: $30.6 million) relating to future payments and/or future potential payments on products. Of the $30.6 million at 31 December 2003, we had accrued $19.4 million within creditors (within one year), including $15.6 million for Maxipime and Azactam and $11.2 million within creditors (after one year) for Frova. These amounts were paid and/or released during 2004.